Genmab A/S operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genmab A/S with three other
miscellaneous service companies in Europe:
Bavarian Nordic AS
sales of 1.02 billion Danish Kroner [US$149.25 million]
of which 100%
was Medical Research),
Bachem Holding AG
(208.60 million Swiss Francs [US$210.71 million]
of which 84%
was Active Pharmaceutical Ingredients), and
Pharma Mar SA
based in Spain
(193.82 million Euro [US$210.90 million]
of which 65%
was Biotech Sector).
Genmab A/S reported sales of 1.13 billion Danish Kroner (US$165.70 million)
December of 2015.
increase of 33.2%
versus 2014, when the company's sales were 850.39 million Danish Kroner.
This was the fourth straight year of sales growth at Genmab A/S.